Ligand Pharmaceuticals - Biopharma's Technology and Capital …
Ligand invests in the clinical development and commercialization of high-value medicines. We manage one of the largest and most diverse portfolios of biopharmaceutical royalties in the …
Ligand Pharmaceuticals Incorporated - Investor Relations
Oct 30, 2025 · Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and commercialization of …
Ligand Reports First Quarter 2025 Financial Results
May 8, 2025 · Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing …
Royalty Portfolio - Ligand Pharmaceuticals
Today, Ligand manages one of the largest and most diverse portfolios of biopharmaceutical royalties in the industry, with more than 90 partnered commercial and development-stage …
Ligand Pharmaceuticals Incorporated - Stock Info
6 days ago · All 3m NASDAQ:LGND News Releases Sep 1 Sep 8 Sep 15 Sep 22 Sep 29 Oct 6 Oct 13 Oct 20 Oct 27 Nov 3 Nov 10 Nov 17 Nov 24 2020 2021 2022 2023 2024 2025 140 160 …
About Us - Ligand Pharmaceuticals
Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and commercialization of high-value programs …
Ligand Pharmaceuticals Incorporated - Ligand Reports Third …
Nov 6, 2025 · For more information, please visit www.ligand.com. Follow Ligand on X and LinkedIn. We use our investor relations website and X as a means of disclosing material non …
Ligand and Medtronic Commit $70 Million in Strategic Capital to ...
Jul 31, 2025 · Ligand’s decision to invest in our partnered programs and our team reflects our shared conviction in the transformative potential of both AVIM therapy and Virtue SAB—our …
Ligand Pharmaceuticals Incorporated - Ligand Reports Second …
Aug 7, 2025 · About Ligand Pharmaceuticals Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines.
News & Events - Press Releases - Ligand Pharmaceuticals
Oct 16, 2025 · Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030 Download , Ligand Announces Proposed Offering of $400 Million of Convertible …